APA (7th ed.) Citation

Younossi, Z. M., Stepanova, M., Jacobson, I. M., Asselah, T., Gane, E. J., Lawitz, E., . . . Henry, L. (2018). Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: Patient-reported outcomes from POLARIS 2 and 3. Alimentary Pharmacology & Therapeutics, 47(2), 259. https://doi.org/10.1111/apt.14423

Chicago Style (17th ed.) Citation

Younossi, Z. M., et al. "Sofosbuvir and Velpatasvir with or Without Voxilaprevir in Direct-acting Antiviral-naïve Chronic Hepatitis C: Patient-reported Outcomes from POLARIS 2 and 3." Alimentary Pharmacology & Therapeutics 47, no. 2 (2018): 259. https://doi.org/10.1111/apt.14423.

MLA (9th ed.) Citation

Younossi, Z. M., et al. "Sofosbuvir and Velpatasvir with or Without Voxilaprevir in Direct-acting Antiviral-naïve Chronic Hepatitis C: Patient-reported Outcomes from POLARIS 2 and 3." Alimentary Pharmacology & Therapeutics, vol. 47, no. 2, 2018, p. 259, https://doi.org/10.1111/apt.14423.